Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
5.04
-0.12 (-2.33%)
At close: Aug 28, 2026, 4:00 PM EDT
5.09
+0.05 (1.07%)
After-hours: Aug 28, 2026, 7:59 PM EDT

Wave Life Sciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
65.3742.73108.3113.313.6540.96
Revenue Growth
-30.42%-60.55%-4.42%3005.10%-91.09%104.03%
Gross Profit
-132.05-140.05-51.38-16.7-112.21-80.91
Operating Income
-217.92-215.38-110.4-68-162.72-127.02
Net Income
-202.47-204.38-97.01-57.51-161.82-122.25
Earnings Per Share
-1.08-1.21-0.70-0.54-2.05-2.36
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
490.6602.07302.08200.3588.5150.56
Total Debt
43.5917.7725.432.1237.6129.92
Net Cash (Debt)
447.01584.3276.67168.2350.88120.65
Net Cash Growth
139.34%111.19%64.46%230.63%-57.83%-22.26%
Net Cash Per Share
2.383.462.001.590.652.33

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-191.58-187.49-151.03-19.43-127.78-88.99
Capital Expenditures
-1.57-0.72-0.94-1.12-1.36-0.56
Free Cash Flow
-193.15-188.21-151.96-20.55-129.14-89.55
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-202.00%--47.44%-14.74%--197.52%
Operating Margin
-333.36%-504.09%-101.94%-60.01%-4459.30%-310.07%
Pretax Margin
-309.73%-478.33%-89.57%-51.36%-4416.06%-298.92%
Profit Margin
-309.73%-478.34%-89.57%-50.76%-4434.72%-298.42%
FCF Margin
-295.46%-440.50%-140.31%-18.13%-3539.11%-218.61%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
15.1972.8117.425.31166.724.51